• Explore /
  • Poster
  • / A phase I multicenter study of the combination of temozolomide and pazopanib in advanced pancreatic neuroendocrine tumors (PNET).

A phase I multicenter study of the combination of temozolomide and pazopanib in advanced pancreatic neuroendocrine tumors (PNET).

Abstract Poster

Authors

null

Aparna Kalyan

Northwestern Medicine Developmental Therapeutics Institute, Chicago, IL

Aparna Kalyan , Sheetal Kircher , Crystal Shereen Denlinger , Jordan Berlin , Mary F Mulcahy , Steven J. Cohen , E. Gabriela Chiorean , Mark Zalupski , Al Bowen Benson III, Halla Sayed Nimeiri

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Clinical Trial Registration Number

NCT01465659

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr TPS492)

DOI

10.1200/jco.2015.33.3_suppl.tps492

Abstract #

TPS492

Poster Bd #

F7

Abstract Disclosures

Similar Posters

First Author: Manali A. Bhave

First Author: Nataliya Volodymyrivna Uboha

First Author: Jaume Capdevila

First Author: Jaume Capdevila